99931-58-5 Usage
Salt form
It is a hydrochloride salt.
Receptor specificity
It is a potent and selective antagonist for the serotonin (5-HT) receptor.
Target receptor
It particularly targets the 5-HT2A receptor.
Potential applications
It has the potential to be used in research and drug development for the treatment of various psychiatric and neurological disorders.
Specific disorders
It may be useful in the treatment of depression, anxiety, and schizophrenia.
Research implications
It may also have applications in the study and understanding of the mechanisms of serotonin receptor function and dysfunction in the brain.
Molecular weight
The molecular weight of the compound is approximately 410.85 g/mol.
Solubility
The compound is likely to be soluble in water due to the presence of the hydrochloride salt.
Stability
The stability of the compound may depend on factors such as temperature, light exposure, and humidity.
Safety precautions
As with any chemical compound, appropriate safety precautions should be taken when handling and using this compound, including the use of personal protective equipment (PPE) and following proper disposal procedures.
Check Digit Verification of cas no
The CAS Registry Mumber 99931-58-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,9,9,3 and 1 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 99931-58:
(7*9)+(6*9)+(5*9)+(4*3)+(3*1)+(2*5)+(1*8)=195
195 % 10 = 5
So 99931-58-5 is a valid CAS Registry Number.
99931-58-5Relevant articles and documents
Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
-
, (2008/06/13)
Disubstituted N,N-piperazinyl derivatives are disclosed wherein one substituent is a pyrimidin-2-yl ring and the other is a 4 carbon chain attached to a p-fluorophenyl ring at the terminal carbon. The terminal carbon of this butylene chain is also bonded to an oxygen atom as part of a carbonyl, carbinol, or ketal functionality. These compounds possess psychotropic properties, particularly atypical antipsychotic activity of good duration. By virtue of pre-clinical pharmacological testing, these compounds appear useful as potential antipsychotic agents which lack the typical movement disorder side-effects of standard antipsychotic agents.